ASH 2021 | Addressing disparities in lymphoma treatment
Francine Foss
• 11 Dec 2021
Francine Foss, MD, Yale University School of Medicine, New Haven, CT, talks on potential disparities in lymphoma treatment and outcomes, especially in African-American patients with cutaneous T-cell lymphoma (CTCL), who may be perceived to have inferior outcomes. An analysis of patients across various centers will elucidate any potential associations between certain patient populations and treatment outcomes. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.
